Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine.
10.1016/j.joim.2021.07.001
- Author:
Rui-Jin QIU
1
;
Min LI
2
;
Jia-Yuan HU
3
;
Jing CHEN
4
;
Hong-Cai SHANG
5
Author Information
1. Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China.
2. The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing 100029, China.
3. Dermatology Department, Beijing Hospital of Traditional Chinese Medicine, Beijing 100010, China.
4. Department of Health Care, Baokang Hospital, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China. Electronic address: cjshcsyc@126.com.
5. Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China. Electronic address: shanghongcai@foxmail.com.
- Publication Type:Research Support, Non-U.S. Gov't
- Keywords:
Clinical trials;
Integrative medicine;
Methodology;
Outcome assessment;
Traditional Chinese medicine
- MeSH:
Cross-Sectional Studies;
Delphi Technique;
Endpoint Determination;
Medicine, Chinese Traditional;
Research Design;
Treatment Outcome
- From:
Journal of Integrative Medicine
2021;19(5):389-394
- CountryChina
- Language:English
-
Abstract:
Clinical trial outcome reporting differs between studies integrating traditional Chinese medicine (TCM) and Western medicine, so that some clinical trials are not eligible for inclusion in a systematic review. The excluded studies are therefore less widely disseminated, and even valid studies are less likely to yield impact. This problem may be addressed by developing core outcome sets (COSs) for integrative medicine in specific healthcare areas. The first stage of development is to define the scope of the COS for integrative medicine, the second stage is to establish the need for such a COS, and the third stage is to develop a protocol and register the COS. The final stage involves three steps: (i) development of a comprehensive list of outcomes (including efficacy outcomes and safety outcomes and TCM syndromes) using systematic review, qualitative or cross-sectional research, and reviews of package inserts and medical records; (ii) merging and grouping of outcomes within domains; (iii) conducting two rounds of Delphi survey and consensus meetings with a range of stakeholders. The final COS will include a general COS and core TCM syndrome- set. Development of COSs for clinical trials of integrative medicine may help to standardize outcome reporting and reduce publication bias in the future.
